All Posts

Recent data suggests that use of GLP-1s is highest for perimenopausal women in the United States. Despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose in this population. Full article here . .

Another pickle since women are often prescribed hormonal contraception in the form of birth control pills or IUDs to manage symptoms of perimenopause regardless of need for pregnancy prevention. Check out the full article here .

https://goop.com/wellness/health/gender-bias-in-medical-field/?srsltid=AfmBOoqLLpApMbuKJp1KWGyV7-sghbi58AAA_R9mxfilkTwIPaAcj-Bm

https://www.nytimes.com/2025/06/17/well/perimenopause-sleep-tips.html

Women typically experience perimenopause four to eight years before entering menopause. Past studies show about 47% of perimenopausal women experience sleep disorders. New research says there may be a link between estrogen levels and sleep in perimenopausal women.

Acne, bloating, and migraines are some of the most common symptoms reported by women in Oura’s perimenopausal age range.

“We had a significant number of women who are typically thought to be too young for perimenopause tell us that they have high levels of perimenopause-related symptoms,” Liudmila Zhaunova, director of science at Flo, said. “It’s important that we keep doing research to understand better what is happening with these women so that they can get the care they need.”